In this regard, the interaction of ADAM15 with integrin αvβ3 has been shown to influence non-small-cell lung cancer (NSCLC) proliferation and metastasis through focal adhesion kinase (FAK) activation and signaling [181]. Here, PTK2 is linked to non-small cell lung carcinoma.